Table 2 SERA SARS-CoV-2 IgG or IgM panel sensitivity as compared with various ELISAs in NAT positive subjects.
Cohort | Serological test | n | SERA sensitivity (% 95% CI) | ELISA sensitivity (% 95% CI) |
|---|---|---|---|---|
Yale | Spike S1 IgG and IgM ELISA | 315 | 77 [71.8–81.1] | 79 [73.8–82.9] |
LabCorp | EuroImun S1 ELISA (IgG) | 235 | 82 [76.7–86.5] | 75 [69.4–80.4] |
LabCorp | N Antigen ELISA (IgG) | 235 | 82 [76.7–86.5] | 86 [80.4–89.4] |
SBCH | Spike S1 IgG and IgM ELISA | 82 | 52 [41.8–62.9] | 48 [37.1–58.2] |
SBCH | Nucleoprotein IgG and IgM ELISA | 82 | 52 [41.8–62.9] | 50 [39.4–60.6] |
